Oncology Drugs Market Research Report, Growth & Forecast

The global Tafasitamab market size is expected to reach $ 812 million by 2032, rising at a market growth of 11.5% CAGR during the forecast period (2026-2032). Tafasitamab is a humanized CD19-targeted...

The global radiotherapy market is expected to grow from USD 7.98 billion in 2026 to USD 10.68 billion by 2031, registering a CAGR of 6.0% during the forecast period. The advancements in radiotherapy t...

According to our (Global Info Research) latest study, the global Cancer mTOR Inhibitors market size was valued at US$ 8201 million in 2025 and is forecast to a readjusted size of US$ 14311 million by...

According to our (Global Info Research) latest study, the global Cancer Tubulin Inhibitors market size was valued at US$ 4284 million in 2025 and is forecast to a readjusted size of US$ 7311 million b...

According to our (Global Info Research) latest study, the global Oncogene-Targeted Drugs market size was valued at US$ 66452 million in 2025 and is forecast to a readjusted size of US$ 109166 million...

The global Cancer mTOR Inhibitors market size is expected to reach $ 14311 million by 2032, rising at a market growth of 8.3% CAGR during the forecast period (2026-2032). Cancer mTOR Inhibitors are a...

The global Cancer Tubulin Inhibitors market size is expected to reach $ 7311 million by 2032, rising at a market growth of 7.9% CAGR during the forecast period (2026-2032). Cancer Tubulin Inhibitors a...

The global Oncogene-Targeted Drugs market size is expected to reach $ 109166 million by 2032, rising at a market growth of 7.3% CAGR during the forecast period (2026-2032). Oncogene-Targeted Drugs are...

The global radiotherapy market size was valued at USD 7.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 10.1 Billion by 2034, exhibiting a CAGR of 3.48% during 2026-2...

The global radiodermatitis market size was valued at USD 529.9 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 679.0 Million by 2034, exhibiting a CAGR of 2.71% from 20...

Highlights & Findings: Research MethodologyFirst Cereblon E3 Ligase Modulator Drug Expected By 2030Market Relevance Of Cereblon E3 Ligase Modulators DrugsInsight On Cereblon E3 Ligase Modulator Drugs...

According to our (Global Info Research) latest study, the global Baccatin III market size was valued at US$ 411 million in 2025 and is forecast to a readjusted size of US$ 545 million by 2032 with a C...

According to our (Global Info Research) latest study, the global Belvarafenib market size was valued at US$ 5.14 million in 2025 and is forecast to a readjusted size of US$ 40.86 million by 2032 with...

According to our (Global Info Research) latest study, the global Capivasertib market size was valued at US$ 749 million in 2025 and is forecast to a readjusted size of US$ 2761 million by 2032 with a...

According to our (Global Info Research) latest study, the global Hyperthermic Chemotherapy Perfusion Equipment market size was valued at US$ 46.46 million in 2025 and is forecast to a readjusted size...

According to our (Global Info Research) latest study, the global Hyperthermic Perfusion System market size was valued at US$ 46.46 million in 2025 and is forecast to a readjusted size of US$ 64.33 mil...

According to our (Global Info Research) latest study, the global Selinexor Tablets market size was valued at US$ 150 million in 2025 and is forecast to a readjusted size of US$ 364 million by 2032 wit...

According to our (Global Info Research) latest study, the global Talacotuzumab market size was valued at US$ 75.11 million in 2025 and is forecast to a readjusted size of US$ 117 million by 2032 with...

According to our (Global Info Research) latest study, the global Talazoparib Tosylate market size was valued at US$ 2325 million in 2025 and is forecast to a readjusted size of US$ 4576 million by 203...

According to our (Global Info Research) latest study, the global TQB2450 market size was valued at US$ 85.40 million in 2025 and is forecast to a readjusted size of US$ 322 million by 2032 with a CAGR...

According to our (Global Info Research) latest study, the global Tralametinib market size was valued at US$ 7.72 million in 2025 and is forecast to a readjusted size of US$ 75.89 million by 2032 with...

According to our (Global Info Research) latest study, the global Tuvonralimab market size was valued at US$ 82.32 million in 2025 and is forecast to a readjusted size of US$ 461 million by 2032 with a...

According to our (Global Info Research) latest study, the global Zolbetuximab market size was valued at US$ 432 million in 2025 and is forecast to a readjusted size of US$ 2557 million by 2032 with a...

The global Baccatin III market size is expected to reach $ 545 million by 2032, rising at a market growth of 4.1% CAGR during the forecast period (2026-2032). Baccatin III is a natural diterpenoid com...

The global Belvarafenib market size is expected to reach $ 40.86 million by 2032, rising at a market growth of 4.8% CAGR during the forecast period (2026-2032). Belvarafenib is a novel, oral small-mol...

The global Capivasertib market size is expected to reach $ 2761 million by 2032, rising at a market growth of 14.4% CAGR during the forecast period (2026-2032). Capivasertib is an oral, highly selecti...

The global Hyperthermic Chemotherapy Perfusion Equipment market size is expected to reach $ 64.33 million by 2032, rising at a market growth of 4.7% CAGR during the forecast period (2026-2032). A Hype...

The global Hyperthermic Perfusion System market size is expected to reach $ 64.33 million by 2032, rising at a market growth of 4.7% CAGR during the forecast period (2026-2032). A Hyperthermic Perfusi...

The global Selinexor Tablets market size is expected to reach $ 364 million by 2032, rising at a market growth of 11.0% CAGR during the forecast period (2026-2032). Selinexor Tablets are an oral selec...

The global Talacotuzumab market size is expected to reach $ 117 million by 2032, rising at a market growth of 4.8% CAGR during the forecast period (2026-2032). Loncastuximab tesirine (trade name Zynlo...

The global Talazoparib Tosylate market size is expected to reach $ 4576 million by 2032, rising at a market growth of 10.4% CAGR during the forecast period (2026-2032). In 2025, global Talazoparib Tos...

The global TQB2450 market size is expected to reach $ 322 million by 2032, rising at a market growth of 12.7% CAGR during the forecast period (2026-2032). TQB2450 (Bemotuzumab Injection) Is A Independ...

The global Tralametinib market size is expected to reach $ 75.89 million by 2032, rising at a market growth of 22.0% CAGR during the forecast period (2026-2032). Tunlametinib is a novel, highly select...

The global Tuvonralimab market size is expected to reach $ 461 million by 2032, rising at a market growth of 10.4% CAGR during the forecast period (2026-2032). Tuvonralimab is a recombinant humanized...

The global Zolbetuximab market size is expected to reach $ 2557 million by 2032, rising at a market growth of 17.4% CAGR during the forecast period (2026-2032). Zolbetuximab is a recombinant, chimeric...

Global Cancer Peptide Drug Market Opportunity, Approved Drug Dosage, Price, Sales & Clinical Trials Insight 2031 Report Finding & Highlights: Research MethodologyGlobal Cancer Peptide Drug Market Opp...

Global VISTA Inhibitor Market Opportunities & Clinical Trials Insight 2026 Report Findings & Highlights: Research MethodologyFirst VISTA Inhibitor Drug Approval By 2029VISTA Inhibitors Clinical Trial...

The Mexico cancer immunotherapy market size reached USD 1.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.6 Billion by 2034, exhibiting a growth rate (CAGR) of 8.41%...

According to our (Global Info Research) latest study, the global Prostate Spacer market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR o...

According to our (Global Info Research) latest study, the global Targeted Cancer Therapy market size was valued at US$ 135080 million in 2025 and is forecast to a readjusted size of US$ 220500 million...

According to our (Global Info Research) latest study, the global Targeted Oncology Drugs market size was valued at US$ 135080 million in 2025 and is forecast to a readjusted size of US$ 220500 million...

According to our (Global Info Research) latest study, the global Ultrasound Tumor Therapy System (HIFU) market size was valued at US$ 149 million in 2025 and is forecast to a readjusted size of US$ 24...

According to our (Global Info Research) latest study, the global Chemotherapy Clothing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a...

According to our (Global Info Research) latest study, the global Prostate Cancer Hydrogel Spacer market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 20...

The stomach cancer therapeutics market size is expected to grow from US$ 5.32 billion in 2025 to US$ 14.46 billion by 2034; it is projected to register a CAGR of 11.76% during 2026–2034. The rising gl...

According to our (Global Info Research) latest study, the global Hyperthermic Chemotherapy Machine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by...

According to our (Global Info Research) latest study, the global Hyperthermic Intraperitoneal Chemotherapy Equipment market size was valued at US$ million in 2025 and is forecast to a readjusted size...

According to our (Global Info Research) latest study, the global Radiation Therapy Room Radiation Shielding Block market size was valued at US$ million in 2025 and is forecast to a readjusted size of...

According to our (Global Info Research) latest study, the global Radiation Therapy Test Phantom market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 203...

According to our (Global Info Research) latest study, the global X-Ray Superficial Radiation Therapy System market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ mi...